Parnell Pharmaceuticals Holdings Ltd
PARN
PARN was delisted on the 30th of December, 2016.
16 hedge funds and large institutions have $17.9M invested in Parnell Pharmaceuticals Holdings Ltd in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
11% more capital invested
Capital invested by funds: $16.1M → $17.9M (+$1.8M)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
11% less funds holding
Funds holding: 18 → 16 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$174K |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$159K |
| 3 |
JP Morgan Chase
New York
|
+$60.3K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$37.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$565K |
| 2 |
D.E. Shaw & Co
New York
|
-$482K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$161K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$146K |
| 5 |
PA
Perceptive Advisors
New York
|
-$81.4K |
PARN Hedge Fund Activity: Q1 2015 in Review
16 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q1 2015, worth a combined $17.9M — up 11% from $16.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PARN and 1 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Endurant Capital Management, adding an estimated $174K. The largest seller was Deerfield Management, cutting an estimated $565K.
- 16 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q1 2015, down from 18 in Q4 2014.
- Funds reported $17.9M of Parnell Pharmaceuticals Holdings Ltd stock for Q1 2015, up 11% quarter-over-quarter.
- 1 fund opened new Parnell Pharmaceuticals Holdings Ltd positions in Q1 2015 and 3 closed out, a net change of -2 holders.
- The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q1 2015 was Endurant Capital Management, an estimated $174K added.
- The largest Parnell Pharmaceuticals Holdings Ltd seller in Q1 2015 was Deerfield Management, an estimated $565K sold.
Based on aggregated 13F filings for Q1 2015.